Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer

We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC). A 44-year-old female who underwent two cycles of chemotherapy for NSCLC complained of visual blurring in both eyes after the initiation of vandetanib, an anti-epidermal growth factor r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Jeeyun, Wee, Won Ryang, Lee, Jin Hak, Hyon, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178773/
https://www.ncbi.nlm.nih.gov/pubmed/21976946
http://dx.doi.org/10.3341/kjo.2011.25.5.355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178773/
https://www.ncbi.nlm.nih.gov/pubmed/21976946
http://dx.doi.org/10.3341/kjo.2011.25.5.355

Ejemplares similares